Archer D P, Bissonnette B, Ravussin P
Département d'anesthésie, Foothills hospital, Calgary, Canada.
Ann Fr Anesth Reanim. 1996;15(3):359-65. doi: 10.1016/s0750-7658(96)80020-7.
Following subarachnoid haemorrhage, delayed cerebral ischaemia from cerebral vasospasm remains the most important cause of mortality and morbidity in patients with surgically secured aneurysms. Therapy with haemodilution, hypertension and volume expansion has been recommended to prevent and treat delayed cerebral ischaemia in these patients on the basis of uncontrolled clinical series (level of evidence III to V, grade C recommendation). Despite the lack of controlled studies, the maintenance of a cardiac index > 3.5 L.min-1.m-2 and a systolic arterial pressure between 120 and 150 mmHg before clipping and 160 to 200 mmHg thereafter is recommended as a prophylactic or therapeutic measure for vasospasm. Close monitoring of neurological and cardiorespiratory status is important to avoid neurologic and systemic complications.
蛛网膜下腔出血后,因脑血管痉挛导致的迟发性脑缺血仍是手术夹闭动脉瘤患者死亡和致残的最重要原因。基于非对照临床系列研究(证据级别为III至V,推荐等级为C),已建议采用血液稀释、高血压和扩容疗法来预防和治疗这些患者的迟发性脑缺血。尽管缺乏对照研究,但仍建议将心脏指数维持在> 3.5 L·min-1·m-2,夹闭前收缩动脉压维持在120至150 mmHg,夹闭后维持在160至200 mmHg,作为预防或治疗血管痉挛的措施。密切监测神经和心肺状态对于避免神经和全身并发症很重要。